New Delhi: Two days after the World Health Organisation (WHO) put a pause on clinical trials of hydroxychloroquine (HCQ) for COVID-19, the Council of Scientific and Industrial Research (CSIR) said that India will continue the use of the anti-malarial drug.
“I’m sure WHO will take considered call in coming time. We should trust ICMR’s judgement, they are well qualified. Hence, we should continue.”CSIR DG Shekhar Mande
Read the original article here: https://www.india.com/news/india/india-should-continue-use-of-hydroxychloroquine